Cargando…
Canagliflozin Modulates Hypoxia-Induced Metastasis, Angiogenesis and Glycolysis by Decreasing HIF-1α Protein Synthesis via AKT/mTOR Pathway
The microenvironment plays a vital role in tumor progression, and hypoxia is a typical microenvironment feature in nearly all solid tumors. In this study, we focused on elucidating the effect of canagliflozin (CANA), a new class of antidiabetic agents, on hepatocarcinoma (HCC) tumorigenesis under hy...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704642/ https://www.ncbi.nlm.nih.gov/pubmed/34948132 http://dx.doi.org/10.3390/ijms222413336 |
_version_ | 1784621755533361152 |
---|---|
author | Luo, Jingyi Sun, Pengbo Zhang, Xun Lin, Guanglan Xin, Qilei Niu, Yaoyun Chen, Yang Xu, Naihan Zhang, Yaou Xie, Weidong |
author_facet | Luo, Jingyi Sun, Pengbo Zhang, Xun Lin, Guanglan Xin, Qilei Niu, Yaoyun Chen, Yang Xu, Naihan Zhang, Yaou Xie, Weidong |
author_sort | Luo, Jingyi |
collection | PubMed |
description | The microenvironment plays a vital role in tumor progression, and hypoxia is a typical microenvironment feature in nearly all solid tumors. In this study, we focused on elucidating the effect of canagliflozin (CANA), a new class of antidiabetic agents, on hepatocarcinoma (HCC) tumorigenesis under hypoxia, and demonstrated that CANA could significantly inhibit hypoxia-induced metastasis, angiogenesis, and metabolic reprogramming in HCC. At the molecular level, this was accompanied by a reduction in VEGF expression level, as well as a reduction in the epithelial-to-mesenchymal transition (EMT)-related proteins and glycolysis-related proteins. Next, we focused our study particularly on the modulation of HIF-1α by CANA, which revealed that CANA decreased HIF-1α protein level by inhibiting its synthesis without affecting its proteasomal degradation. Furthermore, the AKT/mTOR pathway, which plays an important role in HIF-1α transcription and translation, was also inhibited by CANA. Thus, it can be concluded that CANA decreased metastasis, angiogenesis, and metabolic reprogramming in HCC by inhibiting HIF-1α protein accumulation, probably by targeting the AKT/mTOR pathway. Based on our results, we propose that CANA should be evaluated as a new treatment modality for liver cancer. |
format | Online Article Text |
id | pubmed-8704642 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87046422021-12-25 Canagliflozin Modulates Hypoxia-Induced Metastasis, Angiogenesis and Glycolysis by Decreasing HIF-1α Protein Synthesis via AKT/mTOR Pathway Luo, Jingyi Sun, Pengbo Zhang, Xun Lin, Guanglan Xin, Qilei Niu, Yaoyun Chen, Yang Xu, Naihan Zhang, Yaou Xie, Weidong Int J Mol Sci Article The microenvironment plays a vital role in tumor progression, and hypoxia is a typical microenvironment feature in nearly all solid tumors. In this study, we focused on elucidating the effect of canagliflozin (CANA), a new class of antidiabetic agents, on hepatocarcinoma (HCC) tumorigenesis under hypoxia, and demonstrated that CANA could significantly inhibit hypoxia-induced metastasis, angiogenesis, and metabolic reprogramming in HCC. At the molecular level, this was accompanied by a reduction in VEGF expression level, as well as a reduction in the epithelial-to-mesenchymal transition (EMT)-related proteins and glycolysis-related proteins. Next, we focused our study particularly on the modulation of HIF-1α by CANA, which revealed that CANA decreased HIF-1α protein level by inhibiting its synthesis without affecting its proteasomal degradation. Furthermore, the AKT/mTOR pathway, which plays an important role in HIF-1α transcription and translation, was also inhibited by CANA. Thus, it can be concluded that CANA decreased metastasis, angiogenesis, and metabolic reprogramming in HCC by inhibiting HIF-1α protein accumulation, probably by targeting the AKT/mTOR pathway. Based on our results, we propose that CANA should be evaluated as a new treatment modality for liver cancer. MDPI 2021-12-11 /pmc/articles/PMC8704642/ /pubmed/34948132 http://dx.doi.org/10.3390/ijms222413336 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Luo, Jingyi Sun, Pengbo Zhang, Xun Lin, Guanglan Xin, Qilei Niu, Yaoyun Chen, Yang Xu, Naihan Zhang, Yaou Xie, Weidong Canagliflozin Modulates Hypoxia-Induced Metastasis, Angiogenesis and Glycolysis by Decreasing HIF-1α Protein Synthesis via AKT/mTOR Pathway |
title | Canagliflozin Modulates Hypoxia-Induced Metastasis, Angiogenesis and Glycolysis by Decreasing HIF-1α Protein Synthesis via AKT/mTOR Pathway |
title_full | Canagliflozin Modulates Hypoxia-Induced Metastasis, Angiogenesis and Glycolysis by Decreasing HIF-1α Protein Synthesis via AKT/mTOR Pathway |
title_fullStr | Canagliflozin Modulates Hypoxia-Induced Metastasis, Angiogenesis and Glycolysis by Decreasing HIF-1α Protein Synthesis via AKT/mTOR Pathway |
title_full_unstemmed | Canagliflozin Modulates Hypoxia-Induced Metastasis, Angiogenesis and Glycolysis by Decreasing HIF-1α Protein Synthesis via AKT/mTOR Pathway |
title_short | Canagliflozin Modulates Hypoxia-Induced Metastasis, Angiogenesis and Glycolysis by Decreasing HIF-1α Protein Synthesis via AKT/mTOR Pathway |
title_sort | canagliflozin modulates hypoxia-induced metastasis, angiogenesis and glycolysis by decreasing hif-1α protein synthesis via akt/mtor pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704642/ https://www.ncbi.nlm.nih.gov/pubmed/34948132 http://dx.doi.org/10.3390/ijms222413336 |
work_keys_str_mv | AT luojingyi canagliflozinmodulateshypoxiainducedmetastasisangiogenesisandglycolysisbydecreasinghif1aproteinsynthesisviaaktmtorpathway AT sunpengbo canagliflozinmodulateshypoxiainducedmetastasisangiogenesisandglycolysisbydecreasinghif1aproteinsynthesisviaaktmtorpathway AT zhangxun canagliflozinmodulateshypoxiainducedmetastasisangiogenesisandglycolysisbydecreasinghif1aproteinsynthesisviaaktmtorpathway AT linguanglan canagliflozinmodulateshypoxiainducedmetastasisangiogenesisandglycolysisbydecreasinghif1aproteinsynthesisviaaktmtorpathway AT xinqilei canagliflozinmodulateshypoxiainducedmetastasisangiogenesisandglycolysisbydecreasinghif1aproteinsynthesisviaaktmtorpathway AT niuyaoyun canagliflozinmodulateshypoxiainducedmetastasisangiogenesisandglycolysisbydecreasinghif1aproteinsynthesisviaaktmtorpathway AT chenyang canagliflozinmodulateshypoxiainducedmetastasisangiogenesisandglycolysisbydecreasinghif1aproteinsynthesisviaaktmtorpathway AT xunaihan canagliflozinmodulateshypoxiainducedmetastasisangiogenesisandglycolysisbydecreasinghif1aproteinsynthesisviaaktmtorpathway AT zhangyaou canagliflozinmodulateshypoxiainducedmetastasisangiogenesisandglycolysisbydecreasinghif1aproteinsynthesisviaaktmtorpathway AT xieweidong canagliflozinmodulateshypoxiainducedmetastasisangiogenesisandglycolysisbydecreasinghif1aproteinsynthesisviaaktmtorpathway |